Now showing items 1-2 of 2
Non-viral gene therapy for myocardial engineering
(John Wiley & Sons, Ltd., 2010-05)
Despite significant advances in surgical and pharmacological techniques, myocardial infarction (MI) remains the main cause of morbidity in the developed world because no remedy has been found for the regeneration of infarcted ...
Liposomal gene delivery mediated by tissue-engineered scaffolds
In the absence of any ideal gene delivery carrier despite the recent explosion of novel carrier systems, the current trend is to explore the complementary synergy promised by a combination of delivery systems such as ...